XBiotech's market cap is currently $95.11M. The company's EPS TTM is $-1.072; its P/E ratio is ―; XBiotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 4.01M	$ 18.39M	$ 44.00M	$ 0.00
Gross Profit	$ -1.74M	$ 3.36M	$ 12.57M	$ 9.45M	$ -2.36M
Operating Income	$ -37.51M	$ -34.49M	$ -25.08M	$ -18.28M	$ -31.23M
EBITDA	$ -35.77M	$ -31.88M	$ -22.43M	$ -16.04M	$ -28.87M
Net Income	$ -24.56M	$ -32.90M	$ -17.41M	$ -11.22M	$ 668.63M
Balance Sheet
Cash & Short-Term Investments	$ 200.02M	$ 217.48M	$ 236.98M	$ 237.37M	$ 714.59M
Total Assets	$ 226.62M	$ 246.10M	$ 275.18M	$ 353.74M	$ 816.88M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -200.02M	$ -157.31M	$ -236.98M	$ -237.37M	$ -714.59M
Total Liabilities	$ 7.77M	$ 5.70M	$ 5.79M	$ 5.11M	$ 61.25M
Stockholders' Equity	$ 218.85M	$ 240.40M	$ 269.38M	$ 348.64M	$ 755.63M
Cash Flow
Free Cash Flow	$ -19.09M	$ -15.41M	$ 65.92M	$ -68.88M	$ -18.47M
Operating Cash Flow	$ -18.73M	$ -14.82M	$ 69.44M	$ -65.15M	$ -18.27M
Investing Cash Flow	$ 61.50M	$ -63.89M	$ -3.52M	$ -3.73M	$ 674.80M
Financing Cash Flow	$ -9.00K	$ 0.00	$ -67.01M	$ -409.72M	$ 42.10M

Currency in USD

XBiotech Earnings and Revenue History

Income Statement >

XBiotech Debt to Assets

Balance Sheet >

XBiotech Cash Flow

Cash Flow >

XBiotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing